(Q42989435)

12 November 2017

Effect of ribavirin on virus load and quasispecies distribution in patients infected with hepatitis C virus (English)

1 reference

12 November 2017

1 reference

1 reference

1 reference

1 reference

Lee JH

1

1 reference

12 November 2017

von Wagner M

2

1 reference

12 November 2017

Roth WK

3

1 reference

12 November 2017

Teuber G

4

1 reference

12 November 2017

Sarrazin C

5

1 reference

12 November 2017

Zeuzem S

6

1 reference

12 November 2017

language of work or name

1 reference

1 July 1998

1 reference

12 November 2017

Journal of Hepatology

1 reference

12 November 2017

29

1 reference

12 November 2017

29-35

1 reference

12 November 2017

1

1 reference

Ribavirin small-particle aerosol treatment of influenza

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980175-X

7 January 2021

Biochemistry and clinical applications of ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980175-X

7 January 2021

Lassa fever. Effective therapy with ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980175-X

7 January 2021

Ribavirin treatment for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980175-X

7 January 2021

A pilot study of ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980175-X

7 January 2021

Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980175-X

7 January 2021

Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980175-X

7 January 2021

A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980175-X

7 January 2021

Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980175-X

7 January 2021

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980175-X

7 January 2021

Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980175-X

7 January 2021

Fluctuations in viral load (HCV RNA) are relatively insignificant in untreated patients with chronic HCV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980175-X

7 January 2021

Non-isotopic detection of hepatitis C virus quasispecies by single strand conformation polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980175-X

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980175-X

7 January 2021

Avoiding false positives with PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980175-X

7 January 2021

Evaluation and comparison of different hepatitis C virus genotyping and serotyping assays

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980175-X

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980175-X

7 January 2021

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980175-X

7 January 2021

Quantification of hepatitis C virus RNA by competitive reverse transcription and polymerase chain reaction using a modified hepatitis C virus RNA transcript

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980175-X

7 January 2021

Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980175-X

7 January 2021

Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980175-X

7 January 2021

Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980175-X

7 January 2021

Inhibition of immune functions by antiviral drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980175-X

7 January 2021

Modulation of hepatitis C virus quasispecies heterogeneity by interferon-alpha and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980175-X

7 January 2021

Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980175-X

7 January 2021

10.1016/S0168-8278(98)80175-X

Identifiers

DOI

1 reference

12 November 2017

1 reference